Decades of diversity initiatives later, certain groups remain 'consistently underrepresented' in cancer trials, GAO says
After more than three decades of instituting government policies to improve clinical trial diversity, certain racial and ethnic groups, as well as adolescents, older adults …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
